Exact Mass: 610.0745

Exact Mass Matches: 610.0745

Found 46 metabolites which its exact mass value is equals to given mass value 610.0745, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(-)-Epigallocatechin 3,3'-di-gallate

(2R,3R)-2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,3-di-gallate is found in tea. (-)-Epigallocatechin 3,3-di-gallate is isolated from green tea (Thea sinensis). Isolated from green tea (Thea sinensis). Epigallocatechin 3,3-digallate is found in tea.

(-)-Epigallocatechin 3,5-di-gallate

(2R,3R)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,5-di-gallate is found in tea. (-)-Epigallocatechin 3,5-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,5-digallate is found in tea.

(-)-Epigallocatechin 3,4'-di-gallate

(2R,3R)-2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(-)-Epigallocatechin 3,4-di-gallate is found in tea. (-)-Epigallocatechin 3,4-di-gallate is isolated from tea (Thea sinensis). Isolated from tea (Thea sinensis). Epigallocatechin 3,4-digallate is found in tea.

Saprisartan

1-({3-bromo-2-[2-(trifluoromethanesulphonamido)phenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboximidic acid

C25H22BrF3N4O4S (610.0497)

Saprisartan is an AT1 receptor antagonist. It is based on medications of losartans prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749) C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Quercetin 3-O-xylosyl-glucuronide

(2S,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl (2S,3S,4S,5R,6S)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H26O17 (610.117)

Quercetin 3-o-xylosyl-glucuronide is a member of the class of compounds known as flavonoid-3-o-glucuronides. Flavonoid-3-o-glucuronides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid at the C3-position. Quercetin 3-o-xylosyl-glucuronide is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Quercetin 3-o-xylosyl-glucuronide can be found in a number of food items such as summer grape, common grape, rubus (blackberry, raspberry), and highbush blueberry, which makes quercetin 3-o-xylosyl-glucuronide a potential biomarker for the consumption of these food products.

Dolabellin

C24H32Cl2N2O8S2 (610.0977)

Epigallocatechin 5,7,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 5,7,-di-O-gallate

C29H22O15 (610.0959)

Gallocatechin 7,3-di-O-gallate

(2R,3S) -3,5,7,3,4,5-Hexahydroxyflavan 7,3-di-O-gallate

C29H22O15 (610.0959)

Epigallocatechin 3,3,-di-O-gallate

(2R,3R) -3,5,7,3,4,5-Hexahydroxyflavan 3,3,-di-O-gallate

C29H22O15 (610.0959)

Saprisartan

1-({3-bromo-2-[2-(trifluoromethane)sulfonamidophenyl]-1-benzofuran-5-yl}methyl)-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide

C25H22BrF3N4O4S (610.0497)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Bis(2-Ethylhexyl) Chlorendate

C25H36Cl6O4 (610.0745)

1H,1H,2H,2H-PERFLUORODECYLTRIETHOXYSILANE

C16H19F17O3Si (610.0832)

silicon phthalocyanine dichloride

C32H16Cl2N8Si (610.0644)

Vat Red 32

C36H16Cl2N2O4 (610.0487)

CHLORO ALUMINUM CHLORO PHTHALOYANINE

C32H17AlCl2N8 (610.0769)

Rivaroxaban Impurity 12

C25H24Cl2N4O6S2 (610.0514)

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-[(N-acetyl-S-arsono-L-cysteinyl)amino]-2-deoxy-alpha-D-glucopyranoside

C17H31AsN2O15S (610.0661)

Quercetin 3-O-xylosyl-glucuronide

C26H26O17 (610.117)

c-di-UMP

C18H20N4O16P2-2 (610.035)

6-[5-[3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-4-oxochromen-2-yl]-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H26O17 (610.117)

8-{[9-carboxy-4-(methoxycarbonyl)phenazin-2-yl]sulfanyl}-9-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C30H18N4O9S (610.0794)

2-[3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

5-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

4-[(2s,3r)-3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

methyl 2-[1-({7,7-dichloro-3-[2-(1,2-dihydroxyethyl)-1,3-thiazole-4-carbonyloxy]-2-methyloctanoyl}oxy)-2-methylpropyl]-1,3-thiazole-4-carboxylate

C24H32Cl2N2O8S2 (610.0977)

6,7,13-trihydroxy-14-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13-trihydroxy-14-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C26H26O17 (610.117)

6,7,13-trihydroxy-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13-trihydroxy-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C26H26O17 (610.117)

2-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)phenyl]-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

(2r,3s)-7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

4-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,6-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

5-[3,5-dihydroxy-7-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,3-dihydroxyphenyl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)

methyl 2-[(1s)-1-{[(2r,3s)-7,7-dichloro-3-{2-[(1r)-1,2-dihydroxyethyl]-1,3-thiazole-4-carbonyloxy}-2-methyloctanoyl]oxy}-2-methylpropyl]-1,3-thiazole-4-carboxylate

C24H32Cl2N2O8S2 (610.0977)

7-hydroxy-5-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C29H22O15 (610.0959)